92 related articles for article (PubMed ID: 31864672)
1. Corrigendum to "Controlled release of NELL-1 protein from chitosan/hydroxyapatite-modified TCP particles" [Int. J. Pharmaceut. 511(1) (2016) 79-89].
Zhang Y; Dong R; Park Y; Bohner M; Zhang X; Ting K; Soo C; Wu BM
Int J Pharm; 2020 Jan; 574():118938. PubMed ID: 31864672
[No Abstract] [Full Text] [Related]
2. Corrigendum to "Paclitaxel-loaded polymeric nanoparticles combined with chronomodulated chemotherapy on lung cancer: In vitro and in vivo evaluation" [Int. J. Pharmaceut. 516 (2017) 313-322].
Hu J; Fu S; Peng Q; Han Y; Xie J; Zan N; Chen Y; Fan J
Int J Pharm; 2020 Jan; 573():118878. PubMed ID: 31784050
[No Abstract] [Full Text] [Related]
3. Corrigendum to "A special issue dedicated to the 2021 meeting of the French Society for Nanomedicine" [Int. J. Pharmaceut. 638 (2023) 122928].
Garanger E; Mignet N; Pichon C; Rols MP; Sancey L
Int J Pharm; 2023 Oct; 645():123375. PubMed ID: 37709599
[No Abstract] [Full Text] [Related]
4. Corrigendum to "pH-responsive and targeted delivery of chrysin via folic acid-functionalized mesoporous silica nanocarrier for breast cancer therapy" [Int. J. Pharmaceut. 631 (2023) 122555].
Ghosh N; Kundu M; Ghosh S; Das AK; De S; Das J; Sil PC
Int J Pharm; 2023 Oct; 645():123363. PubMed ID: 37690916
[No Abstract] [Full Text] [Related]
5. Chitosan-stablized bovine serum albumin nanoparticles having ability to control the release of NELL-1 protein.
Li Y; Song H; Xiong S; Tian T; Liu T; Sun Y
Int J Biol Macromol; 2018 Apr; 109():672-680. PubMed ID: 29288032
[TBL] [Abstract][Full Text] [Related]
6. Corrigendum to "In vitro combinatorial anticancer effects of 5-fluorouracil and curcumin loaded N,O-carboxymethyl chitosan nanoparticles toward colon cancer and in vivo pharmacokinetic studies" [Eur. J. Pharmaceut. Biopharmaceut. 88 (2014) 238-251].
Anitha A; Sreeranganathan M; Chennazhi KP; Lakshmanan VK; Jayakumar R
Eur J Pharm Biopharm; 2019 Jun; 139():44-46. PubMed ID: 31054763
[No Abstract] [Full Text] [Related]
7. Beta-tricalcium phosphate particles as a controlled release carrier of osteogenic proteins for bone tissue engineering.
Hu J; Hou Y; Park H; Lee M
J Biomed Mater Res A; 2012 Jul; 100(7):1680-6. PubMed ID: 22447727
[TBL] [Abstract][Full Text] [Related]
8. Two-phase electrospinning to incorporate growth factors loaded chitosan nanoparticles into electrospun fibrous scaffolds for bioactivity retention and cartilage regeneration.
Wang C; Hou W; Guo X; Li J; Hu T; Qiu M; Liu S; Mo X; Liu X
Mater Sci Eng C Mater Biol Appl; 2017 Oct; 79():507-515. PubMed ID: 28629047
[TBL] [Abstract][Full Text] [Related]
9. Development and characterization of hydroxyapatite/β-TCP/chitosan composites for tissue engineering applications.
Shavandi A; Bekhit Ael-D; Ali MA; Sun Z; Gould M
Mater Sci Eng C Mater Biol Appl; 2015 Nov; 56():481-93. PubMed ID: 26249618
[TBL] [Abstract][Full Text] [Related]
10. Corrigendum to "Evaluation of chitosan quaternary ammonium salt-modified resin denture base material" [Int. J. Biol. Macromol. 85 (2016) 102-110].
Song R; Zhong Z; Lin L
Int J Biol Macromol; 2017 Mar; 96():323. PubMed ID: 28013070
[No Abstract] [Full Text] [Related]
11. Chitosan/gelatin/platelet gel enriched by a combination of hydroxyapatite and beta-tricalcium phosphate in healing of a radial bone defect model in rat.
Oryan A; Alidadi S; Bigham-Sadegh A; Meimandi-Parizi A
Int J Biol Macromol; 2017 Aug; 101():630-637. PubMed ID: 28363647
[TBL] [Abstract][Full Text] [Related]
12. Corrigendum to ''A glucose-targeted mixed micellar formulation outperforms Genexol in breast cancer cells'' [Euro. J. Pharmaceut. Biopharmaceut. 114 (2017) 305-316].
Moretton MA; Bernabeu E; Grotz E; Gonzalez L; Zubillaga M; Chiappetta DA
Eur J Pharm Biopharm; 2017 Oct; 119():454. PubMed ID: 28738178
[No Abstract] [Full Text] [Related]
13. Erratum to 'Increasing vaccine supply with low dead-volume syringes and needles' [Int. J. Pharmaceut. 608 (2021) 121053].
Le Daré B; Bacle A; Lhermitte R; Lesourd F; Lurton Y
Int J Pharm; 2022 Feb; 613():121443. PubMed ID: 35012794
[No Abstract] [Full Text] [Related]
14. An ectopic study of tissue-engineered bone with Nell-1 gene modified rat bone marrow stromal cells in nude mice.
Hu JZ; Zhang ZY; Zhao J; Zhang XL; Liu GT; Jiang XQ
Chin Med J (Engl); 2009 Apr; 122(8):972-9. PubMed ID: 19493425
[TBL] [Abstract][Full Text] [Related]
15. Effects of hydroxyapatite particulate debris on the production of cytokines and proteases in human fibroblasts.
Ninomiya JT; Struve JA; Stelloh CT; Toth JM; Crosby KE
J Orthop Res; 2001 Jul; 19(4):621-8. PubMed ID: 11518271
[TBL] [Abstract][Full Text] [Related]
16. Corrigendum to "Grafting of aniline derivatives onto chitosan and their applications for removal of reactive dyes from industrial effluents" [Int. J. Biol. Macromol. 95 (2017) 393-403, doi: 10.1016/j.ijbiomac.2016.11.075].
Abbasian M; Jaymand M; Niroomand P; Farnoudiyan-Habibi A; Karaj-Abad SG
Int J Biol Macromol; 2017 May; 98():575. PubMed ID: 28208111
[No Abstract] [Full Text] [Related]
17. Maxillary sinus floor elevation using BMP-2 and Nell-1 gene-modified bone marrow stromal cells and TCP in rabbits.
Xia L; Xu Y; Chang Q; Sun X; Zeng D; Zhang W; Zhang X; Zhang Z; Jiang X
Calcif Tissue Int; 2011 Jul; 89(1):53-64. PubMed ID: 21584647
[TBL] [Abstract][Full Text] [Related]
18. Corrigendum to "Synthesis, characterization and cytocompatibility studies of α-chitin hydrogel/nano hydroxyapatite composite scaffolds" [Int. J. Biol. Macromol. 49 (2011) 20-31].
Kumar PTS; Srinivasan S; Lakshmanan VK; Tamura H; Nair SV; Jayakumar R
Int J Biol Macromol; 2019 Oct; 138():1138-1141. PubMed ID: 31279592
[No Abstract] [Full Text] [Related]
19. Corrigendum to "Fabrication of chitin-chitosan/nano TiO
Jayakumar R; Ramachandran R; Divyarani VV; Chennazhi KP; Tamura H; Nair SV
Int J Biol Macromol; 2019 Aug; 135():1285-1287. PubMed ID: 31256977
[No Abstract] [Full Text] [Related]
20. Corrigendum to "Fabrication of chitin-chitosan/nano ZrO
Jayakumar R; Ramachandran R; Kumar PTS; Divyarani VV; Srinivasan S; Chennazhi KP; Tamura H; Nair SV
Int J Biol Macromol; 2019 Aug; 135():1283-1284. PubMed ID: 31255323
[No Abstract] [Full Text] [Related]
[Next] [New Search]
